Literature DB >> 29699136

Difference in mitochondrial gene expression in granulosa cells between recombinant FSH and hMG cycles under in vitro fertilization and transfer.

Natsuho Saito1, Yoshiki Yamashita1, Yoshihiro Ono1, Yoko Higuchi1, Atsushi Hayashi1, Yoko Yoshida1, Hikaru Yamamoto1, Sachiko Kawabe1, Mika Kamada1, Yoshito Terai1, Masahide Ohmichi1.   

Abstract

PURPOSE: Examination of the mitochondrial mRNA expression in granulosa cells from an unspecified population of infertile patients to evaluate whether recombinant follicle stimulating hormone (recFSH) is more effective in producing higher quality embryo rates compared with human menopausal gonadotropin (hMG).
METHOD: Thirty-nine patients who underwent the in vitro fertilization and embryo transfer program were retrospectively examined. Patients were administered recFSH (n = 18) or hMG (n = 20) in a long protocol where GnRH agonist was used. Granulosa cells were obtained during oocyte retrieval and examined for mitochondria mRNA expression ratio against GAPDH. Expressions of mitochondria mRNA were evaluated by real-time PCR analysis.
RESULTS: The high-quality embryo rate in the hMG cycle was higher than in the recFSH cycle, and the total dose of hMG showed a positive correlation with the expression level of mitochondrial genes in granulosa cells. Moreover, mitochondria mRNA expression was higher in the hMG cycle than in the recFSH cycle.
CONCLUSIONS: Compared with recFSH, hMG induces a higher mitochondrial gene expression ratio in granulosa cells at the time of oocyte retrieval and, therefore, may lead to higher quality embryo rates.

Entities:  

Keywords:  Granulosa cell; IVF‐ET; Mitochondria; Recombinant FSH; hMG

Year:  2013        PMID: 29699136      PMCID: PMC5904594          DOI: 10.1007/s12522-013-0147-z

Source DB:  PubMed          Journal:  Reprod Med Biol        ISSN: 1445-5781


  27 in total

1.  Recombinant follicle-stimulating hormone (follitropin beta, Puregon) yields higher pregnancy rates in in vitro fertilization than urinary gonadotropins.

Authors:  H J Out; S G Driessen; B M Mannaerts; H J Coelingh Bennink
Journal:  Fertil Steril       Date:  1997-07       Impact factor: 7.329

2.  The use of mitochondrial nutrients to improve the outcome of infertility treatment in older patients.

Authors:  Yaakov Bentov; Navid Esfandiari; Eliezer Burstein; Robert F Casper
Journal:  Fertil Steril       Date:  2009-09-03       Impact factor: 7.329

3.  Moderate and severe endometriosis is associated with alterations in the cell cycle of granulosa cells in patients undergoing in vitro fertilization and embryo transfer.

Authors:  M Toya; H Saito; N Ohta; T Saito; T Kaneko; M Hiroi
Journal:  Fertil Steril       Date:  2000-02       Impact factor: 7.329

Review 4.  Structure-function relationship of recombinant follicle stimulating hormone (Puregon).

Authors:  R de Leeuw; J Mulders; G Voortman; F Rombout; J Damm; L Kloosterboer
Journal:  Mol Hum Reprod       Date:  1996-05       Impact factor: 4.025

5.  Levels of apoptosis in human granulosa cells seem to be comparable after therapy with a gonadotropin-releasing hormone agonist or antagonist.

Authors:  Franca Giampietro; Silvia Sancilio; Gian Mario Tiboni; Rosa Alba Rana; Roberta Di Pietro
Journal:  Fertil Steril       Date:  2006-02       Impact factor: 7.329

6.  Differences in steroidogenic acute regulatory protein expression from the luteinizing-granulosa cells of patients undergoing in vitro fertilization with embryo transfer: implications for cycle outcomes.

Authors:  Jennifer Phy; Douglas M Stocco; Samuel D Prien
Journal:  Am J Obstet Gynecol       Date:  2002-05       Impact factor: 8.661

7.  Incidence of apoptotic bodies in membrana granulosa of the patients participating in an in vitro fertilization program.

Authors:  K Nakahara; H Saito; T Saito; M Ito; N Ohta; N Sakai; N Tezuka; M Hiroi; H Watanabe
Journal:  Fertil Steril       Date:  1997-02       Impact factor: 7.329

8.  Apoptosis as a function of ovarian reserve in women undergoing in vitro fertilization.

Authors:  D B Seifer; A C Gardiner; K A Ferreira; J J Peluso
Journal:  Fertil Steril       Date:  1996-10       Impact factor: 7.329

9.  Single-dose pharmacokinetics and pharmacodynamics of recombinant human follicle-stimulating hormone (Org 32489*) in gonadotropin-deficient volunteers.

Authors:  B Mannaerts; Z Shoham; D Schoot; P Bouchard; J Harlin; B Fauser; H Jacobs; F Rombout; H Coelingh Bennink
Journal:  Fertil Steril       Date:  1993-01       Impact factor: 7.329

10.  Comparison of mitochondrial DNA contents in human embryos with good or poor morphology at the 8-cell stage.

Authors:  David Pei-Cheng Lin; Chun Chia Huang; Hui Mei Wu; Tzu Chun Cheng; Chung I Chen; Maw Sheng Lee
Journal:  Fertil Steril       Date:  2004-01       Impact factor: 7.329

View more
  2 in total

1.  Mitochondrial metabolic substrate utilization in granulosa cells reflects body mass index and total follicle stimulating hormone dosage in in vitro fertilization patients.

Authors:  Richard J Kordus; Akhtar Hossain; Henry E Malter; Holly A LaVoie
Journal:  J Assist Reprod Genet       Date:  2020-09-15       Impact factor: 3.412

2.  The ovarian sensitivity index is predictive of live birth chances after IVF in infertile patients.

Authors:  A Weghofer; D H Barad; S K Darmon; V A Kushnir; D F Albertini; N Gleicher
Journal:  Hum Reprod Open       Date:  2020-12-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.